Back to search results

Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer

Israel
RecruitingPHASE1, PHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Metastatic Breast Cancer

Locations
  • Shaare Zedek Medical Center, Jerusalem, Israel
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)